Robert Conley
InvestorChief Research and Development Officer at atai Life Sciences
Find your path to Robert
15 people in our graph share verified history with Robert — schools, employers, funds. One of them is your warm intro.
About
Robert Conley is Chief Research and Development Officer of AtaiBeckley, a role he took in 2025 after serving as Chief Scientific and Medical Officer at Beckley Psytech. His earlier industry roles include Senior Vice President at Eleusis and Chief Science Officer, Neuroscience at Eli Lilly and Co. He previously held academic positions at the University of Pittsburgh and the University of Maryland School of Medicine, where he remains an Adjunct Professor of Psychiatry and Psychopharmacology, and holds an MD from Maryland and a BA from Johns Hopkins University.
Invests in
BiotechMental Health
Colleagues at atai Life Sciences
Frequently asked questions
- Who is Robert Conley?
- Robert Conley is Chief Research and Development Officer of AtaiBeckley, a role he took in 2025 after serving as Chief Scientific and Medical Officer at Beckley Psytech. His earlier industry roles include Senior Vice President at Eleusis and Chief Science Officer, Neuroscience at Eli Lilly and Co. He previously held academic positions at the University of Pittsburgh and the University of Maryland School of Medicine, where he remains an Adjunct Professor of Psychiatry and Psychopharmacology, and holds an MD from Maryland and a BA from Johns Hopkins University.
- Where does Robert Conley work?
- Robert Conley is Chief Research and Development Officer at atai Life Sciences.
- What does Robert Conley invest in?
- Robert Conley invests in Biotech, Mental Health.